Life Science News
Latest updates from the biotech and pharma world
Hologic mammography studies show promise of AI in breast cancer detection
Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles
ARPA-H launches program to fund autonomous stroke-treating robots
FDA delays decision on Ascendis' dwarfism prospect by 3 months
Ceribell scores FDA nod for detecting seizures in preterm newborns
AI may be the key to reigniting VC interest in biotech: PitchBook
Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns
GE HealthCare presents photon-counting CT system for FDA review
AbbVie launches lab space award program for Quebec biotechs
FTC outlines antitrust case against Edwards' $945M JenaValve acquisition
US commission recommends federal research revamp to avoid losing global biotech edge
Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3
#mRNA flu#Pfizer mRNA#flu vaccine#greater efficacy#greater effectiveness
CDC updates website to say vaccines may cause autism without new evidence
#CDC updates#updates website#webpage undercut#medical community#community consensus
The Cooper Companies under activist pressure to split—in different ways
#Cooper Companies#past month#activist pressure#Activist investors#outlined dueling
Moderna's reshaping rolls on with 3 more pipeline purges
#Moderna reshaping#vaccine Spikevax#pipeline purges#infectious diseases#mRNA programs
How a 'healthy exchange of ideas' with RFK Jr. kick-started FDA's gene therapy push
#Tim Hunt#Human Services#early March#kick-started FDA#FDA gene
GE HealthCare to acquire imaging software provider Intelerad for $2.3B
#cardiology practices#clinical trials#provider Intelerad#imaging business#software provider
Fierce Biotech Layoff Tracker 2025: Applied Tx lays off 46% of staff; Ensoma makes cuts
#Fierce Biotech#Layoff Tracker#Ensoma makes#makes cuts#editorial team
In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation
#Marty Makary#Director Marty#FDA Director#FDA stability#biotech CEOs